Company Filing History:
Years Active: 2017
Title: Stephanie Mueller: Innovator in Polypeptide Conjugation
Introduction
Stephanie Mueller is a notable inventor based in Eppelheim, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of polypeptide conjugation. Her innovative work has led to the development of a unique method for producing polypeptide conjugates that have potential applications in various therapeutic areas.
Latest Patents
Stephanie Mueller holds a patent for "IGF-I poly (ethylene glycol) conjugates." This patent describes a method for producing a polypeptide conjugated to poly (ethylene glycol). The process involves several steps, including providing a nucleic acid encoding an expression construct, expressing the nucleic acid in a cell, and recovering the expression construct. Additionally, it includes the conjugation of a target peptide to poly (ethylene glycol) and the incubation of the expression construct with a specific trypsin mutant. This innovative approach enhances the therapeutic potential of polypeptides.
Career Highlights
Throughout her career, Stephanie has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Stephanie has collaborated with several talented individuals, including Friederike Hesse and Eva Hoess. These collaborations have enriched her research and have played a crucial role in the advancement of her innovative projects.
Conclusion
Stephanie Mueller is a pioneering inventor whose work in polypeptide conjugation has the potential to impact the biotechnology field significantly. Her contributions, highlighted by her patent and collaborations, showcase her dedication to innovation and research.